About this trial
Orofacial clefts, the most common congenital craniofacial malformations, have a complex etiology involving an interaction between genetic and environmental factors.
Chromosomal abnormalities, including structural variations, represent a major cause of human pathology. Recently, technological developments and the introduction of next-generation sequencing (NGS) technologies have revolutionized the field of medical genetics.
Optical genome mapping (OGM) is an innovative, high-resolution "long read" technique that enables the identification of all classes of chromosomal variation, consisting in the direct visualization of long, labeled DNA molecules throughout the genome. This technology is gradually becoming an essential tool for studying onco-hematology and constitutional genetic pathologies The purpose of this study is to search for structural chromosomal variants (SV) or copy number variants (CNV) not identifiable either by cytogenetic methods nor by "short read" NGS "short read, in individuals with oral-facial clefts with no genetic diagnosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals with syndromic, complex or familial oral-facial clefts
With no established genetic diagnosis
Followed up at the Amiens-Picardie University Hospital
Disqualifiers
genetic diagnosis of oral-facial cleft
No health insurance affiliation
Patient under guardianship or curatorship, under safeguard of justice or deprived under public law
Pregnant, parturient or breast-feeding woman
Trial design
Single group
Treatments tested in this trial
blood withdrawal
Geneticblood withdrawal for genetic testing
Treatment groups
Trial outcomes
Primary outcomes
Identification of a structural chromosomal variant
Identification of a structural chromosomal variant involved in the genesis of orofacial clefts by studying the genetic characteristics of individuals with orofacial clefts.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.